Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL is a concentrate used for allergy testing and immunotherapy. This product, manufactured by Greer Laboratories, Inc., is available in a 50 mL multi-dose vial.

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL is primarily used for diagnosing and treating allergies. It contains extracts derived from the Dermatophagoides pteronyssinus mite, which is a common allergen. This concentrate is often utilized in allergy testing to identify sensitivities and in immunotherapy to help build tolerance to the allergen. The primary use of Dermatophagoides pteronyssinus is to aid in the management of allergic reactions caused by exposure to dust mites.

When administered, Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL may cause localized reactions such as redness, swelling, or itching at the injection site. These effects are generally mild and temporary. In some cases, individuals may experience systemic reactions, which can include symptoms like sneezing, nasal congestion, or mild respiratory discomfort. It is important to monitor for any adverse reactions following administration.

This concentrate should be handled with care and administered by a healthcare professional. It is essential to follow proper storage and handling guidelines to maintain the integrity of the product. Individuals with a history of severe allergic reactions should be closely monitored during and after administration. Always consult with a healthcare provider before using this product to ensure it is appropriate for your specific needs.

Standardized Mite Dermatophagoides pteronyssinus 30000 [AU]/mL may interact with other medications or treatments. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Certain medications, such as antihistamines or beta-blockers, may affect the results of allergy testing or the effectiveness of immunotherapy. Always consult with a healthcare professional to discuss potential interactions.